What is NDC 14335-133?

14335-133 is the product NDC for Sodium Nitroprusside, Sodium nitroprusside .2 mg/mL injection, solution, listed with the FDA by Hainan Poly Pharm. Co., Ltd.. It has 1 package NDC, shown above in 10- and 11-digit form.

Hainan Poly Pharm. Co., Ltd., NDC labeler code 14335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Sodium Nitroprusside?

16 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Sodium Nitroprusside NDC 14335-133

NDC codes

FDA NDC Directory

Product NDC (as listed)14335-133Labeler and product segments. Claims need a package NDC.

Product NDC at billing width14335-0133Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
14335-133-01	1433501330114335013301	1 VIAL in 1 CARTON (14335-133-01) / 100 mL in 1 VIALMarketed from Dec 31, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sodium Nitroprusside
Generic name (nonproprietary): sodium nitroprusside
Active ingredients: Sodium nitroprusside — .2 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Hainan Poly Pharm. Co., Ltd.NDC labeler code 14335
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215846
Marketing start: Dec 31, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Vasodilation (Physiologic effect)
Identifiers: Product ID 14335-133_e826d769-c243-f0ac-e053-2995a90afcffSPL ID e826d769-c243-f0ac-e053-2995a90afcffSPL set ID 72a9b7df-3a2f-4c16-93a9-b645bc0e8143RxCUI 1876368, 1999185, 2052423UNII EAO03PE1TCUPC 0314335133013, 0314335134010
Pharmacologic class: Vasodilator

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N414335013301 followed by a unit qualifier and the quantity

Package 14335-0133-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 31, 2022. This label includes a boxed warning.

Indications (excerpt from the label)

Sodium nitroprusside is a direct acting vasodilator indicated for: •Immediate reduction of blood pressure ( 1.1 ) •Producing controlled hypotension to reduce bleeding during surgery. ( 1.2 ) •Treatment of acute heart failure to reduce left ventricular end-diastolic pressure, pulmonary capillary wedge pressure, peripheral vascular resistance and mean arterial blood pressure. ( 1.3 ) 1.1 Immediate Reduction of Blood Pressure Sodium nitroprusside is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises. 1.2 Induction and Maintenance of Controlled Hypotension Sodium nitroprusside indicated for induction and maintenance of controlled hypote…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 14335-133

What is NDC 14335-133?: 14335-133 is the product NDC for Sodium Nitroprusside, Sodium nitroprusside .2 mg/mL injection, solution, listed with the FDA by Hainan Poly Pharm. Co., Ltd.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Sodium Nitroprusside.
What is the active ingredient?: Sodium nitroprusside.
Who is the labeler?: Hainan Poly Pharm. Co., Ltd., NDC labeler code 14335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sodium Nitroprusside?: 16 other product NDCs are listed under this name. See all Sodium Nitroprusside NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Sodium Nitroprusside NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Sodium Nitroprusside	Sodium nitroprusside 50 mg/2mL	Injection, SolutionIntravenous	Dr.Reddy's Laboratories Inc.,	75907-290	75907-0290-11
Sodium Nitroprusside	Sodium nitroprusside 50 mg/2mL	InjectionIntravenous	Caplin Steriles Limited	65145-101	65145-0101-01
sodium nitroprusside	Sodium nitroprusside 50 mg/2mL	Injection, Solution, ConcentrateIntravenous	Hainan Poly Pharm. Co., Ltd.	14335-131	14335-0131-01
Sodium Nitroprusside	Sodium nitroprusside .2 mg/mL	Injection, SolutionIntravenous	Hainan Poly Pharm. Co., Ltd.	14335-132	14335-0132-01
Sodium Nitroprusside	Sodium nitroprusside .5 mg/mL	Injection, SolutionIntravenous	Hainan Poly Pharm. Co., Ltd.	14335-134	14335-0134-01
Sodium Nitroprusside	Sodium nitroprusside 50 mg/2mL	InjectionIntravenous	BE Pharmaceuticals Inc.	71839-120	71839-0120-01
Sodium Nitroprusside	Sodium nitroprusside 50 mg/2mL	InjectionIntravenous	AuroMedics Pharma LLC	55150-320	55150-0320-01
sodium nitroprusside	Sodium nitroprusside 50 mg/2mL	Injection, Solution, ConcentrateIntravenous	Slate Run Pharmaceuticals, LLC	70436-028	70436-0028-80
Sodium nitroprusside	Sodium nitroprusside 25 mg/mL	Injection, Solution, ConcentrateIntravenous	Mylan Institutional LLC	67457-999	67457-0999-02
Sodium Nitroprusside	Sodium nitroprusside 50 mg/2mL	InjectionIntravenous	Armas Pharmaceuticals Inc.	72485-105	72485-0105-01

All 17 Sodium Nitroprusside NDCs

Other NDCs under ANDA 215846

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215846
Product	Strength	Form · route	Labeler	Product NDC
Sodium Nitroprusside	Sodium nitroprusside .2 mg/mL	Injection, SolutionIntravenous	Hainan Poly Pharm. Co., Ltd.	14335-132
Sodium Nitroprusside	Sodium nitroprusside .5 mg/mL	Injection, SolutionIntravenous	Hainan Poly Pharm. Co., Ltd.	14335-134
sodium nitroprusside in 0.9% sodium chloride	Sodium nitroprusside .2 mg/mL	InjectionIntravenous	Slate Run Pharmaceuticals, LLC	70436-205
sodium nitroprusside in 0.9% sodium chloride	Sodium nitroprusside .2 mg/mL	InjectionIntravenous	Slate Run Pharmaceuticals, LLC	70436-206
sodium nitroprusside in 0.9% sodium chloride	Sodium nitroprusside .5 mg/mL	InjectionIntravenous	Slate Run Pharmaceuticals, LLC	70436-207